Cerevel Therapeutics Holdings, Inc.

CIK 1805387 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cerevel Therapeutics Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Aug 12, 202415-12G0001193125-24-198363
Aug 5, 2024EFFECT9999999995-24-002395
Aug 5, 202440000950170-24-090908
Aug 5, 202440000950170-24-090841
Aug 5, 202440000950170-24-090909
Aug 5, 202440000078003-24-000169
Aug 5, 2024EFFECT9999999995-24-002397
Aug 5, 202440000950170-24-090853
Aug 5, 202440000950170-24-090822
Aug 5, 202440000950170-24-090801
Aug 5, 202440000950170-24-090790
Aug 5, 202440000950170-24-090842
Aug 5, 202440000950170-24-090830
Aug 5, 202440000950170-24-090827
Aug 5, 202440000950170-24-090815
Aug 5, 202440000950170-24-090813
Aug 5, 202440000950170-24-090861
Aug 5, 202440000950170-24-090806
Aug 5, 202440000950170-24-090903
Aug 5, 2024SC 13D/A0000078003-24-000168
Aug 5, 2024EFFECT9999999995-24-002401
Aug 5, 2024EFFECT9999999995-24-002392
Aug 5, 202440000950170-24-090851
Aug 5, 202440000950170-24-090833
Aug 5, 2024SC 13D/A0001193125-24-193966